Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Русский
English
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PRTC
#5777
PureTech Health plc American Depositary Shares
16.7
7
+0.72%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+0.72%
Monthly Change
-11.69%
6 month change
-4.17%
Cambio anual
-5.79%
Cierres anteriores
16.6
5
Open
17.0
0
Bid
Ask
Low
16.7
7
High
17.0
0
Volumen
2
Markets
Acciones
Atención Sanitaria
PRTC
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Total assets
—
Total liabilities
—
Total equity
—
Total liabilities & shareholders' equities
—
Total debt
—
Net debt
—
PureTech Health plc - American Depositary Shares
PureTech Health is an American biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange.
Noticias
Деупирфенидон получил статус орфанного препарата для редкого заболевания легких
Deupirfenidone receives orphan drug status for rare lung disease
Деупирфенидон PureTech получил статус орфанного препарата от FDA и ЕС
PureTech’s deupirfenidone receives FDA and EU orphan drug status for IPF
PureTech Health plc (PRTC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Глава PureTech выступит на конференции J.P. Morgan Healthcare
PureTech CEO to present at J.P. Morgan Healthcare Conference
PureTech Health назначает Роберта Лайна постоянным CEO
PureTech Health appoints Robert Lyne as permanent CEO
PureTech provides update on AGM results following shareholder concerns
Акции PureTech падают после встречи с FDA по препарату от ИЛФ
PureTech stock falls after FDA meeting on IPF drug